1	F.H.	_	NNP	_	_	2	NAME	_	_
2	Faulding	_	NNP	_	_	11	SBJ	_	_
3	&	_	CC	_	_	2	COORD	_	_
4	Co.	_	NNP	_	_	3	CONJ	_	_
5	,	_	,	_	_	2	P	_	_
6	an	_	DT	_	_	9	NMOD	_	_
7	Australian	_	JJ	_	_	9	NMOD	_	_
8	pharmaceuticals	_	NNS	_	_	9	NMOD	_	_
9	company	_	NN	_	_	2	APPO	_	_
10	,	_	,	_	_	2	P	_	_
11	said	_	VBD	_	_	0	ROOT	_	_
12	its	_	PRP$	_	_	15	NMOD	_	_
13	Moleculon	_	NNP	_	_	15	NMOD	_	_
14	Inc.	_	NNP	_	_	15	NMOD	_	_
15	affiliate	_	NN	_	_	16	SBJ	_	_
16	acquired	_	VBD	_	_	11	OBJ	_	_
17	Kalipharma	_	NNP	_	_	16	OBJ	_	_
18	Inc.	_	NNP	_	_	17	POSTHON	_	_
19	for	_	IN	_	_	16	ADV	_	_
20	$	_	$	_	_	19	PMOD	_	_
21	23	_	CD	_	_	20	DEP	_	_
22	million	_	CD	_	_	20	DEP	_	_
23	.	_	.	_	_	11	P	_	_

1	Kalipharma	_	NNP	_	_	2	SBJ	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	a	_	DT	_	_	7	NMOD	_	_
4	New	_	JJ	_	_	5	AMOD	_	_
5	Jersey-based	_	JJ	_	_	7	NMOD	_	_
6	pharmaceuticals	_	NNS	_	_	7	NMOD	_	_
7	concern	_	NN	_	_	2	PRD	_	_
8	that	_	WDT	_	_	9	SBJ	_	_
9	sells	_	VBZ	_	_	7	NMOD	_	_
10	products	_	NNS	_	_	9	OBJ	_	_
11	under	_	IN	_	_	9	MNR	_	_
12	the	_	DT	_	_	14	NMOD	_	_
13	Purepac	_	NNP	_	_	14	NMOD	_	_
14	label	_	NN	_	_	11	PMOD	_	_
15	.	_	.	_	_	2	P	_	_

1	Faulding	_	NNP	_	_	2	SBJ	_	_
2	said	_	VBD	_	_	0	ROOT	_	_
3	it	_	PRP	_	_	4	SBJ	_	_
4	owns	_	VBZ	_	_	2	OBJ	_	_
5	33	_	CD	_	_	6	NMOD	_	_
6	%	_	NN	_	_	4	OBJ	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	Moleculon	_	NNP	_	_	11	NMOD	_	_
9	's	_	POS	_	_	8	SUFFIX	_	_
10	voting	_	NN	_	_	11	NMOD	_	_
11	stock	_	NN	_	_	7	PMOD	_	_
12	and	_	CC	_	_	4	COORD	_	_
13	has	_	VBZ	_	_	12	CONJ	_	_
14	an	_	DT	_	_	15	NMOD	_	_
15	agreement	_	NN	_	_	13	OBJ	_	_
16	to	_	TO	_	_	15	NMOD	_	_
17	acquire	_	VB	_	_	16	IM	_	_
18	an	_	DT	_	_	21	NMOD	_	_
19	additional	_	JJ	_	_	21	NMOD	_	_
20	19	_	CD	_	_	21	NMOD	_	_
21	%	_	NN	_	_	17	OBJ	_	_
22	.	_	.	_	_	2	P	_	_

1	That	_	DT	_	_	2	NMOD	_	_
2	stake	_	NN	_	_	12	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	together	_	RB	_	_	5	PMOD	_	_
5	with	_	IN	_	_	2	NMOD	_	_
6	its	_	PRP$	_	_	10	NMOD	_	_
7	convertible	_	JJ	_	_	10	NMOD	_	_
8	preferred	_	VBN	_	_	10	NMOD	_	_
9	stock	_	NN	_	_	10	NMOD	_	_
10	holdings	_	NNS	_	_	5	PMOD	_	_
11	,	_	,	_	_	2	P	_	_
12	gives	_	VBZ	_	_	0	ROOT	_	_
13	Faulding	_	NNP	_	_	12	OBJ	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	right	_	NN	_	_	12	OBJ	_	_
16	to	_	TO	_	_	15	NMOD	_	_
17	increase	_	VB	_	_	16	IM	_	_
18	its	_	PRP$	_	_	19	NMOD	_	_
19	interest	_	NN	_	_	17	OBJ	_	_
20	to	_	TO	_	_	17	DIR	_	_
21	70	_	CD	_	_	22	NMOD	_	_
22	%	_	NN	_	_	20	PMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	Moleculon	_	NNP	_	_	27	NMOD	_	_
25	's	_	POS	_	_	24	SUFFIX	_	_
26	voting	_	NN	_	_	27	NMOD	_	_
27	stock	_	NN	_	_	23	PMOD	_	_
28	.	_	.	_	_	12	P	_	_

